Mindray Medical International Return on Equity:16.03% for March 31, 2013
Mindray Medical International Return on Equity Chart
Mindray Medical International Historical Return on Equity DataPro Data Export
There is no data for the selected date range.
|Data for this Date Range|
|March 31, 2013||16.03%|
|Dec. 31, 2012||14.82%|
|Sept. 30, 2012||14.66%|
|June 30, 2012||15.36%|
|March 31, 2012||15.33%|
|Dec. 31, 2011||15.97%|
|Sept. 30, 2011||16.13%|
|June 30, 2011||16.76%|
|March 31, 2011||17.33%|
|Dec. 31, 2010||18.54%|
|Sept. 30, 2010||19.86%|
|June 30, 2010||23.03%|
About Return on Equity (ROE)
Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).
ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.
Investors generally are interested in company's that have high, increasing returns on equity.
MR Return on Equity Benchmarks
|West Pharmaceutical Services||11.67%|
MR Return on Equity Rankings
1012 of 7593
93 of 650 in Healthcare
12 of 67 in Medical Instruments & Supplies
MR Return on Equity Range, Past 5 Years
Street Insider May 8